Richard A Shlofmitz

Jun 13, 2024 | jamanetwork.com | Allison Kratka |Rita F. Redberg |Robert W. Yeh |Richard A Shlofmitz

Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis Robert W. Yeh, MD, MSc; Richard Shlofmitz, MD; Jeffrey Moses, MD; William Bachinsky, MD; Suhail Dohad, MD; Steven Rudick, MD; Robert Stoler, MD; Brian K. Jefferson, MD; William Nicholson, MD; John Altman, MD; Cinthia Bateman, MD; Amar Krishnaswamy, MD; J. Aaron Grantham, MD; Frank J. Zidar, MD; Steven P. Marso, MD; Jennifer A. Tremmel, MD, MS; Cindy Grines, MD; Mustafa I. Ahmed, MD; Azeem Latib, MD; Behnam Tehrani, MD; J.

Jun 13, 2024 | jamanetwork.com | Robert W. Yeh |Ajay Kirtane |Richard A Shlofmitz |Jeffrey W. Moses

Coronary In-Stent Restenosis Treated With Paclitaxel-Coated Balloon vs Uncoated Balloon—Reply Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis Robert W. Yeh, MD, MSc; Richard Shlofmitz, MD; Jeffrey Moses, MD; William Bachinsky, MD; Suhail Dohad, MD; Steven Rudick, MD; Robert Stoler, MD; Brian K. Jefferson, MD; William Nicholson, MD; John Altman, MD; Cinthia Bateman, MD; Amar Krishnaswamy, MD; J. Aaron Grantham, MD; Frank J.

Mar 9, 2024 | jamanetwork.com | Robert W. Yeh |Richard A Shlofmitz |Jeffrey W. Moses |William Bachinsky

Key PointsQuestion  Is treatment with a coronary paclitaxel-coated balloon superior to an uncoated balloon for 1-year target lesion failure in patients undergoing percutaneous coronary intervention for in-stent restenosis? Findings  In a multicenter randomized trial of 600 patients designed to support US regulatory approval, target lesion failure was significantly lower in the paclitaxel-coated balloon group (17.9%) compared with the uncoated balloon group (28.6%) (P = .003).

Aug 27, 2023 | nejm.org | Richard A Shlofmitz |Matthew Price |Jonathan Hill |Francesco Prati

October 19, 2023N Engl J Med 2023; 389:1466-1476 DOI: 10.1056/NEJMoa2305861 AbstractData regarding clinical outcomes after optical coherence tomography (OCT)–guided percutaneous coronary intervention (PCI) as compared with angiography-guided PCI are limited. In this prospective, randomized, single-blind trial, we randomly assigned patients with medication-treated diabetes or complex coronary-artery lesions to undergo OCT-guided PCI or angiography-guided PCI.

Jul 22, 2023 | nature.com | Richard A Shlofmitz

AbstractPlaques identified by Coronary CT angiography (CCTA) are important in clinical diagnosis and primary prevention. High-risk plaque features by CCTA have been extensively validated using optical coherence tomography (OCT). However, since their general diagnostic performance and limitations have not been fully investigated, we sought to compare CCTA with OCT among consecutive vessel sections.